NCT06521489View on ClinicalTrials.gov

Asymmetrical HFNCO vs Standard HFNCO Post Cardiac Surgery Patients

NAActive, not recruitingINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

February 28, 2026

Conditions
Hypoxemic Respiratory Failure
Interventions
DEVICE

Asymmetrical High Flow Nasal Cannula Oxygenation

Asymmetrical High Flow Nasal Cannula Oxygenation will be implemented in this study group. (1st study group, 60l/min airflow, 60% fiO2)

DEVICE

Conventional High Flow Nasal Cannula Oxygenation

Conventional High Flow Nasal Cannula Oxygenation will be implemented in this study group. (2nd study group, 60l/min airflow, 60% fiO2)

Trial Locations (1)

10676

Evangelismos General Hospital of Athens, Athens

All Listed Sponsors
lead

National and Kapodistrian University of Athens

OTHER

NCT06521489 - Asymmetrical HFNCO vs Standard HFNCO Post Cardiac Surgery Patients | Biotech Hunter | Biotech Hunter